0001181431-13-017867.txt : 20130319
0001181431-13-017867.hdr.sgml : 20130319
20130319171350
ACCESSION NUMBER: 0001181431-13-017867
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130315
FILED AS OF DATE: 20130319
DATE AS OF CHANGE: 20130319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Khattar Jack A.
CENTRAL INDEX KEY: 0001539937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 13702636
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 1550 EAST GUDE DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
rrd374289.xml
X0306
4
2013-03-15
0
0001356576
SUPERNUS PHARMACEUTICALS INC
SUPN
0001539937
Khattar Jack A.
C/O SUPERNUS PHARMACEUTICALS, INC.
1550 EAST GUDE DRIVE
ROCKVILLE
MD
20850
1
1
0
0
President, CEO
Common Stock
2013-03-15
4
P
0
10000
6.1461
A
412058
D
Common Stock
1125000
I
By the KBT Trust
Employee Stock Option (Right to Buy)
7.90
2023-02-05
Common Stock
300000
300000
D
Stock Appreciation Right
7.90
2023-02-05
Common Stock
92000
92000
D
The option and the stock appreciation rights vest in four equal annual installments beginning on February 5, 2014.
The reported purchase was made pursuant to a pre-arranged program for buying stock adopted on December 27, 2012, pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.13 to $6.20, inclusive. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
/s/ Gregory S. Patrick, as attorney-in-fact
2013-03-19